SCHEMBL30867287

SCHEMBL30867287

CCOC(=O)c1c(Br)nc(C(F)(F)F)c(Cl)c1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.43
MAPT P10636 3/20 0.40
POLB P06746 2/20 0.40
KMT2A Q03164 2/20 0.40
ALDH1A1 P00352 4/20 0.39
HPGD P15428 3/20 0.39
LMNA P02545 1/20 0.39
PKM P14618 1/20 0.39
HTT P42858 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
IDO1 P14902 1/20 0.38
NPSR1 Q6W5P4 1/20 0.37
ATF1 P18846 1/20 0.36
NFKB1 P19838 1/20 0.36
PDE4D Q08499 1/20 0.36
GABRP O00591 1/20 0.36
GABRD O14764 1/20 0.36
GABRA1 P14867 1/20 0.36
GABRB1 P18505 1/20 0.36
GABRG2 P18507 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30867279 0.84 KDM4E (0.50) KDM4EMAPTPOLBKMT2AALDH1A1
SCHEMBL10373408 0.80 KDM4E (0.48) KDM4EMAPTPOLBKMT2AALDH1A1
SCHEMBL6733600 0.79 KDM4E (0.45) KDM4EMAPTPOLBKMT2AALDH1A1
SCHEMBL10370416 0.77 KDM4E (0.48) KDM4EMAPTPOLBKMT2AALDH1A1
SCHEMBL9726366 0.77 KDM4E (0.50) KDM4EMAPTPOLBKMT2AALDH1A1
SCHEMBL10373414 0.75 KDM4E (0.44) KDM4EMAPTPOLBKMT2AALDH1A1
SCHEMBL30867520 0.74 ALDH1A1 (0.40) KDM4EMAPTPOLBKMT2AALDH1A1
SCHEMBL31426629 0.74 ALDH1A1 (0.40) KDM4EMAPTPOLBKMT2AALDH1A1
SCHEMBL30867525 0.74 ALDH1A1 (0.40) KDM4EMAPTPOLBKMT2AALDH1A1
SCHEMBL25387538 0.74 KDM4E (0.42) KDM4EMAPTPOLBKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4583867-A2 SODIUM CHANNEL BLOCKING COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE Latigo Biotherapeutics, Inc. (US) 2025-07-16 EP disclosed
WO-2024054622-A2 SODIUM CHANNEL BLOCKING COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE LATIGO BIOTHERAPEUTICS, INC. (US) 2024-03-14 WO disclosed